Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels

Further lowering of low-density lipoprotein (LDL) cholesterol (LDL-C) levels in patients with already low LDL-C produced benefit in terms of reduced risk for major vascular events with no serious adverse effects, a large meta-analysis suggests.

Source: JAMA Cardiology

Read this article


Related stories